本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

方舟生物医药

28.80
0.0000
成交量:- -
成交额:68.83万
市值:8.49亿
市盈率:-57.85
高:28.80
开:28.80
低:28.80
收:28.80
52周最高:28.80
52周最低:1.56
股本:2,949.04万
流通股本:478.82万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.4978
每股收益(LYR):-0.3704
净资产收益率:-20.05%
总资产收益率:-14.35%
市净率:26.07
市盈率(LYR):-77.76

数据加载中...

2024/06/19

SEC问询函

Form CORRESP - Correspondence
2024/06/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/05

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/04/04

重要事件披露

Form 8-K - Current report
2024/04/03

重要事件披露

Form 8-K - Current report
2024/04/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2024/02/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/31

重要事件披露

Form 8-K - Current report